» Articles » PMID: 29043702

N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase C-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome

Overview
Date 2017 Oct 19
PMID 29043702
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Paracrine disruption of growth factors in women with polycystic ovarian syndrome (PCOS) results in production of low quality oocyte, especially following ovulation induction. The aim of this study was to investigate the effects of metformin (MET), N-acetylcysteine (NAC) and their combination on the hormonal levels and expression profile of GDF-9, BMP-15 and c-kit, as hallmarks of oocyte quality, in PCOS patients.

Materials And Methods: This prospective randomized, double-blind, placebo controlled trial aims to study the effects of MET, NAC and their combination (MET+NAC) on expression of GDF-9, BMP-15 and c-kit mRNA in oocytes [10 at the germinal vesicle (GV) stage, 10 at the MI stage, and 10 at the MII stage from per group] derived following ovulation induction in PCOS. Treatment was carried out for six weeks, starting on the third day of previous cycle until oocyte aspiration. The expression of GDF9, BMP15 and c-kit were determined by quantitative real time polymerase chain reaction (RT-qPCR) and western blot analysis. Data were analyzed with one-way ANOVA.

Results: The follicular fluid (FF) level of c-kit protein significantly decreased in the NAC group compared to the other groups. Significant correlations were observed between the FF soluble c-kit protein with FF volume, androstenedione and estradiol. The GDF-9 expression in unfertilized mature oocytes were significantly higher in the NAC group compared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups. The c-kit expression in unfertilized mature oocytes were significantly lower in the NAC group compared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups (Registration number: IRCT201204159476N1).

Conclusion: We concluded that NAC can improve the quality of oocytes in PCOS.

Citing Articles

N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome.

Fang Y, Ding H, Li T, Zhao X, Luo D, Liu Y J Ovarian Res. 2024; 17(1):205.

PMID: 39415242 PMC: 11484282. DOI: 10.1186/s13048-024-01528-8.


Downregulation of Expression During Apoptosis in the Hippocampus of Diabetic Male Wistar Rats: Ameliorative Effects of Seed Extract.

Fahimi S, Oryan S, Ahmadi R, Eidi A Iran J Pharm Res. 2023; 21(1):e132071.

PMID: 36915407 PMC: 10007996. DOI: 10.5812/ijpr-132071.


Effects of N-acetylcysteine on Growth, Viability, and Ultrastructure of In Vitro Cultured Bovine Secondary Follicles.

Nascimento D, Azevedo V, Barroso P, Barrozo L, Silva B, Silva A Animals (Basel). 2022; 12(22).

PMID: 36428416 PMC: 9687016. DOI: 10.3390/ani12223190.


Role of N-acetylcysteine treatment in women with advanced age undergoing IVF/ICSI cycles: A prospective study.

Li X, Wang Z, Wang H, Xu H, Sheng Y, Lian F Front Med (Lausanne). 2022; 9:917146.

PMID: 36267623 PMC: 9577027. DOI: 10.3389/fmed.2022.917146.


The reaggregation of normal granulosa-cumulus cells and mouse oocytes with polycystic ovarian syndrome in vitro: An experimental study.

Moradi A, Ghasemian F, Mashayekhi F Int J Reprod Biomed. 2022; 19(11):987-996.

PMID: 34977456 PMC: 8717076. DOI: 10.18502/ijrm.v19i11.9914.


References
1.
Palomba S, Falbo A, La Sala G . Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2014; 12:3. PMC: 3895676. DOI: 10.1186/1477-7827-12-3. View

2.
Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S . Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Fertil Steril. 2009; 94(1):198-204. DOI: 10.1016/j.fertnstert.2009.03.004. View

3.
Persani L, Rossetti R, Di Pasquale E, Cacciatore C, Fabre S . The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders. Hum Reprod Update. 2014; 20(6):869-83. DOI: 10.1093/humupd/dmu036. View

4.
Qiao J, Feng H . Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2010; 17(1):17-33. PMC: 3001338. DOI: 10.1093/humupd/dmq032. View

5.
Liu J, Liu M, Ye X, Liu K, Huang J, Wang L . Delay in oocyte aging in mice by the antioxidant N-acetyl-L-cysteine (NAC). Hum Reprod. 2012; 27(5):1411-20. DOI: 10.1093/humrep/des019. View